Mexoage not only integrates immune cell percentage testing and circulating tumor cell (CTC) subtyping, but further analyzes the functional impacts of different drugs on immune cells, omnipotent monocytes (OPMs), and CTCs.
Beyond foundational analyses such as mapping personal immune status and CTC characteristics, Mexoage incorporates testing items for Chinese herbal extracts and pharmaceutical compounds—encompassing a total of 74 active substances across nutritional supplements, natural extracts, traditional Chinese medicine, and commonly used medications. This provides a more comprehensive set of personalized functional data to serve as a reference for health management and wellness planning evaluation.
Immune Cell Percentage Testing utilizes flow cytometry to analyze the proportions of key immune cell populations—including T cells, B cells, and Natural Killer (NK) cells—to assess the overall state of the immune system, serving as an essential baseline for immune function evaluation and health management.
CTC Subtyping employs proprietary cell expansion technology to culture circulating tumor cells (CTCs) and circulating hybrid cells (CHCs) from blood samples, utilizing flow cytometry to analyze eight major cancer cell types as a reference for cancer risk assessment, disease monitoring, and treatment response tracking.
Active Substance & Drug Testing exposes cultured immune cells, OPMs, and CTCs separately to 74 active substances spanning seven major categories: nutrients, peptides, cytokines, growth factors, natural extracts, Chinese herbal extracts, and pharmaceutical drugs. Through functional analysis, it comprehensively evaluates the effects of various active substances on immune cells, OPMs, and CTCs, establishing a personalized cellular response database. Notably, the inclusion of Chinese herbal extracts and common medication testing serves as a reference for evaluating current drug use, integrative Traditional Chinese and Western Medicine therapies, and wellness planning.
Individuals who value health management and wish to gain early insight into their health status
Individuals who wish to understand the impact of health foods, dietary supplements, or commonly used medications on immune cells and CTCs
Collect approximately 90 mL of human peripheral blood at a partner institution. The specimen will be delivered to the laboratory within 24 hours to initiate subsequent cell culture and testing analysis.
Utilize flow cytometry analysis technology to test the proportions of key immune cells, such as T cells, B cells, and NK cells, thereby evaluating individual immune status.
Employ proprietary culture technology to culture and expand immune cells and CTCs for subsequent drug testing.
Utilize 74 active substances across seven major categories to evaluate changes in the activities of immune cells and CTCs separately.
Utilize flow cytometry analysis technology to detect eight cancer-related CTC types and evaluate the potential quantity of CTCs in the body, providing references for early risk assessment and health management.
Integrate and comprehensively analyze all test results to issue an exclusive test report, serving as an important reference for developing personalized treatment plans.
Report Delivered in Approximately 14 Working Days
